Bear Mountain Capital
TEVA icon

Bear Mountain Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bear Mountain Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223 Hold
7
– – ﹤0.01% 190
2026
Q1 		$224 Hold
7
– – ﹤0.01% 173
2025
Q4 		$226 Hold
7
– – ﹤0.01% 175
2025
Q3 		$133 Buy
+7
New +$123 ﹤0.01% 299

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Bear Mountain Capital's TEVA Position: Q2 2026 in Review

Bear Mountain Capital held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 7 shares worth $223. The position accounts for ﹤0.01% of the portfolio, ranked #190.

Bear Mountain Capital first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $226 in Q4 2025. 678 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bear Mountain Capital held 7 shares of Teva Pharmaceutical Industries Limited worth $223 as of Q2 2026.
  • Bear Mountain Capital left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #190 holding.
  • Bear Mountain Capital first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 4 quarters since.
  • Bear Mountain Capital's Teva Pharmaceutical Industries Limited position peaked at $226 in Q4 2025.
  • 678 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.